C
CIN Terminal
Cannabis Investor News
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
QNTM Equity

Quantum BioPharma

NASDAQ · QNTM

—
—
Live Price
Price History 5 Years
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Peer Comparison
Loading peer data…
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Quantum BioPharma (QNTM) — Bullish & Bearish Analyst Opinions

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Quantum BioPharma (QNTM), a cannabis-sector equity listed on NASDAQ. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $12.5.

CIN editorial stance: Event-Driven Opportunity. Setup improving. Analyst upside 214% detected. (3 bullish signals, 0 bearish signals.)

Latest price: $3.98 (+1.66%) on NASDAQ.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for QNTM are maintained by Cannabis Investor News and refreshed throughout the trading day.

Data sources: SEC EDGAR, Yahoo Finance, StockAnalysis.com, and SEDAR+. Editorial signal generated by CIN's proprietary scoring model. Not investment advice.